Control of leukemia driven by T315I escape mutations in BCR-ABL with yeast-based Tarmogen immunotherapy
Year: 2007
Type: article
Source: Molecular Cancer Therapeutics
Institution: University of Colorado Denver
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2265127558
